Yue Webster received her B.S. in Chemistry from Peking University, Beijing, China; her M.S. in Electrical & Computer Engineering from Purdue University, Indianapolis; and her Ph.D. in Health & Biomedical Informatics from Indiana University, Indianapolis. Dr. Webster joined Eli Lilly in 2002 and her experience ranges from computational chemistry software development to target discovery using clinicogenomics datasets. She has co-authored more than 30 publications in peer-review journals, such as Cancer Discovery, Cancer Cell, J. Med. Chem., and Drug Discovery Today. Currently, Dr. Webster is leading the LIGHT (Lilly Insights for Genomics and Human Trial) program in support of Lilly’s Next Generation Research efforts.